Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma

The elimination of chronic hepatitis C infection (CHC) by pegylated interferon plus ribavirin (Peg-IFN/RBV) decreases hepatocellular carcinoma (HCC) recurrence rate. However, the tertiary prevention of HCC recurrence by direct acting antiviral agents (DAA) remains controversial. This study aims to c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Teng, Wei, Jeng, Wen-Juei, Yang, Hwai-I, Chen, Wei-Ting, Hsieh, Yi-Chung, Huang, Chien-Hao, Lin, Chen-Chun, Lin, Chun-Yen, Lin, Shi-Ming, Sheen, I-Shyan
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016942/
https://ncbi.nlm.nih.gov/pubmed/31861706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010023
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky